Buscar
WAVE Life Sciences Ltd
WVEAñadir a la lista de seguimiento
5.510USD
-0.250-4.34%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.09BCap. mercado
PérdidaP/E TTM
Más Datos de WAVE Life Sciences Ltd Compañía
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).
Información de WAVE Life Sciences Ltd
Símbolo de cotizaciónWVE
Nombre de la empresaWAVE Life Sciences Ltd
Fecha de salida a bolsaNov 11, 2015
Director ejecutivoBolno (Paul B)
Número de empleados287
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 11
Dirección7 Straits View
Ciudad
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSingapore
Código postal018936
Teléfono6562363388
Sitio Webhttps://www.wavelifesciences.com/
Símbolo de cotizaciónWVE
Fecha de salida a bolsaNov 11, 2015
Director ejecutivoBolno (Paul B)
Ejecutivos de WAVE Life Sciences Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
334.87K
-2.94%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
57.26K
-79.88%
Dr. Christopher I. Wright, M.D., Ph.D.
Dr. Christopher I. Wright, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
45.63K
--
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
16.11K
-78.81%
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
11.24K
-112.96%
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
4.37K
-744.22%
Dr. Paul B. Bolno, M.D.
Dr. Paul B. Bolno, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Gregory L. (Greg) Verdine, Ph.D.
Dr. Gregory L. (Greg) Verdine, Ph.D.
Director
Director
--
--
Dr. Peter Kolchinsky, Ph.D.
Dr. Peter Kolchinsky, Ph.D.
Independent Director
Independent Director
--
--
Mr. Christian O. Henry
Mr. Christian O. Henry
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
334.87K
-2.94%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
57.26K
-79.88%
Dr. Christopher I. Wright, M.D., Ph.D.
Dr. Christopher I. Wright, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
45.63K
--
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
16.11K
-78.81%
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
11.24K
-112.96%
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
4.37K
-744.22%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de WAVE Life Sciences Ltd?
Los cinco principales accionistas de WAVE Life Sciences Ltd son: Dr. Chandra Vargeese, Ph.D.